scholarly journals Correction to: Staging, recurrence and follow-up of uterine cervical cancer using MRI: Updated Guidelines of the European Society of Urogenital Radiology after revised FIGO staging 2018

2021 ◽  
Author(s):  
Lucia Manganaro ◽  
Yulia Lakhman ◽  
Nishat Bharwani ◽  
Benedetta Gui ◽  
Silvia Gigli ◽  
...  
Keyword(s):  
Cervical Cancer ◽  
European Society ◽  
Uterine Cervical Cancer ◽  
Figo Staging ◽  
Urogenital Radiology

scholarly journals Staging of uterine cervical cancer with MRI: guidelines of the European Society of Urogenital Radiology

2010 ◽  
Vol 21 (5) ◽  
pp. 1102-1110 ◽  
Author(s):  
Corinne Balleyguier ◽  
E. Sala ◽  
T. Da Cunha ◽  
A. Bergman ◽  
B. Brkljacic ◽  
...  
Keyword(s):  
Cervical Cancer ◽  
European Society ◽  
Uterine Cervical Cancer ◽  
Urogenital Radiology

scholarly journals Re-classification of uterine cervical cancer cases treated with radical hysterectomy based on the 2018 FIGO staging system

2021 ◽  
Vol 60 (6) ◽  
pp. 1054-1058
Author(s):  
Daiken Osaku ◽  
Hiroaki Komatsu ◽  
Masayo Okawa ◽  
Yuki Iida ◽  
Shinya Sato ◽  
...  
Keyword(s):  
Cervical Cancer ◽  
Radical Hysterectomy ◽  
Staging System ◽  
Uterine Cervical Cancer ◽  
Figo Staging

scholarly journals Scalp Metastasis of Cervical Cancer With Favorable Outcome

2020 ◽  
Vol 8 (3) ◽  
pp. 333-335
Author(s):  
Elham Saffarieh ◽  
Setare Nassiri ◽  
Maedeh Brahman ◽  
Soheila Amini Moghaddam ◽  
Shima Hosseini
Keyword(s):  
Cervical Cancer ◽  
Multidisciplinary Approach ◽  
Uterine Cervical Cancer ◽  
Radical Excision ◽  
Hematogenous Spread ◽  
Papilloma Virus ◽  
Case Presentation ◽  
Frontal Part ◽  
Scalp Metastasis

Introduction: Carcinoma of the uterine cervix is the most common gynecological malignancies in developing countries. Human papilloma virus is known as the main etiology. In addition, the spread of uterine cervical cancer often occurs through direct local extension and the lymphatics although the hematogenous spread is uncommon. Further, the scalp metastasis of cervical cancer is extremely rare. Case Presentation: In this regard, a 50-year-old woman with scalp metastasis of previous cervical cancer was discussed in the present study. She was suffering from a fast-growing and painful nodule, located on the frontal part of the scalp as a sole site of metastasis. A multidisciplinary approach was considered for her, which consisted of radical excision, followed by radiotherapy and chemotherapy. Given the lack of abundant evidence for the efficacy of this treatment, our patient has fortunately survived for more than two years. Conclusions: During the follow-up period after the completion of treatment, it is not sensible to only focus on the primary site of the tumor and thus entire examination is mandatory in this regard.

scholarly journals Follow-up uterine cervical cancer: study of continue assistance to patient in a health region

2016 ◽  
Vol 20 (4) ◽  
Author(s):  
Ana Cristina Bortolasse de Farias ◽  
Ana Rita Barbieri
Keyword(s):  
Cervical Cancer ◽  
Uterine Cervical Cancer ◽  
Cancer Study ◽  
Health Region

Follow-up results in patients with atypical glandular cells detected on uterine cervical cancer screening

2021 ◽  
Vol 60 (2) ◽  
pp. 94-101
Author(s):  
Yutaka MORIMURA ◽  
Kenta HANO ◽  
Wakako KURITA ◽  
Ryoko TORAIWA ◽  
Junko KAMIO ◽  
...  
Keyword(s):  
Cervical Cancer ◽  
Cancer Screening ◽  
Cervical Cancer Screening ◽  
Uterine Cervical Cancer ◽  
Glandular Cells ◽  
Atypical Glandular Cells

Problems of follow-up in patients with abnormal cytology by mass screening for uterine cervical cancer

2007 ◽  
Vol 46 (5) ◽  
pp. 251-255
Author(s):  
Yutaka MORIMURA ◽  
Seiko CHIBA ◽  
Mariko ITO ◽  
Kazuhiro TAKAHASHI ◽  
Kaoru KANNO ◽  
...  
Keyword(s):  
Cervical Cancer ◽  
Mass Screening ◽  
Uterine Cervical Cancer ◽  
Abnormal Cytology

Revised FIGO staging shows dramatic survival differences in cervical cancer patients with positive lymph nodes in Louisiana.

2019 ◽  
Vol 37 (15_suppl) ◽  
pp. e17010-e17010
Author(s):  
Navya Nair ◽  
Lu Zhang ◽  
Anna Kuan-Celarier ◽  
Xiao-cheng Wu ◽  
Amelia Jernigan
Keyword(s):  
Cervical Cancer ◽  
Staging System ◽  
Figo Stage ◽  
Stage I ◽  
Stage Iii ◽  
Poverty Level ◽  
Stage Iiic ◽  
Figo Staging ◽  
Survival Differences

e17010 Background: With revisions to FIGO cervical cancer staging system in 2018, patients with positive pelvic or para-aortic lymph nodes (LN) are now classified as stage IIIC. Rationale for this change is based on data published in 1990. Methods for work up and treatment of cervical cancer have advanced since then. We aim to determine if updated FIGO staging reflects contemporary survival differences in women with cervical cancer in Louisiana. Methods: Women with FIGO stage I-III cervical cancer diagnosed between 2010 and 2016 were identified from the Louisiana Tumor Registry. Those with < 30 days follow up were excluded. Patients were classified into 3 groups: true stage I & II (LN negative), revised stage IIIC (old stage I or II but positive LN), previous stage III (old FIGO stage IIIA or IIIB). Cox proportional hazards were used to estimate differences in overall and (OS) cause-specific survival (CSS). Covariates of age, race, insurance, census-tract poverty level, and marital status were controlled. Results: 740 patients were included with a median follow up of 40.6 months. Patients in revised stage IIIC group were younger than the others (45.9 yrs vs 47.9 yrs in true stage I&II vs 55yrs in previous stage III, p < 0.0001). True stage I&II patients were more likely to be privately insured (48.9% vs 32.1% revised stage IIIC vs 27.7% previous stage III, p < 0.0001). The groups did not differ by race, poverty level, or marital status. Revised stage IIIC and previous stage III patients had significantly worse survival outcomes compared to true stage I & II in both OS [revised stage IIIC HR 1.93 (1.20-3.11); previous stage III 5.92 (4.27, 8.22)] and CSS [revised stage IIIC HR 2.54 (1.45-4.44); previous stage III HR 7.95 (5.29, 11.94)]. Kaplan-Meier survival curves demonstrate significant differences in both OS and CSS (p < 0.0001) with best outcomes in true stage I&II and worst in previous stage III patients. Conclusions: LN status is an important prognostic indicator for contemporary cervical cancer patients in Louisiana. This analysis provides recent data to support the revised FIGO staging system in upstaging patients with positive LN to stage IIIC as they have significantly worse survival than the true stage I & II patients. Importantly, revised stage IIIC patients who would have previously been stage I & II have strikingly better survival outcomes than women with stage IIIA and IIIB disease. If staging is to be intuitive, the stage III subcategories may need to be redefined.

Sign in / Sign up

Export Citation Format

Share Document